Successful stem cell transplantation after nelarabine, pegylated asparaginase, vincristine, doxorubicin, and prednisone in refractory early T-cell precursor acute lymphoblastic leukemia: A case report
Medwave · 31.05.2023 · 23 (04) · e2664-e2664
DOI: 10.5867/medwave.2023.04.2664 ↗Kurz gefasst
Fallbericht in der Zeitschrift Medwave, online erschienen am 31.05.2023. Verfasst von Marcela Espinoza und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Early T-cell precursor Acute Lymphoblastic Leukemia (ALL) has a dismal prognosis. Nelarabine is a purine nucleoside analog that increases the apoptosis rate in T-cell lymphoblasts. We present a 30-year-old patient diagnosed with T-cell ALL. He was a high-risk patient because of an early precursor phenotype and a complex karyotype that had been refractory to three previous lines of treatment. He started a course of nelarabine (1500 mg/m for three days), pegylated-asparaginase, doxorubicin, vincristine, and prednisone (Nelarabine Peg-Asp AdmVP). He reached complete remission and received an allogeneic sibling hematopoietic stem cell transplant with fludarabine, total body irradiation, and cyclophosphamide as the conditioning regimen. He developed a pulmonary mycosis, which resolved, and grade-2 neurotoxicity in his upper and lower limbs. He was discharged after 40 days and to date remains with 23 months of complete remission. The Nelarabine Peg-Asp AdmVP regimen seems to be effective and safe. Further research is needed to establish it as an induction treatment in refractory early T-cell precursor acute lymphoblastic leucemia.
Zitieren
APA
Espinoza, M., Ramírez, P., Najima, Y., & Rojas-Vallejos, J. (2023). Successful stem cell transplantation after nelarabine, pegylated asparaginase, vincristine, doxorubicin, and prednisone in refractory early T-cell precursor acute lymphoblastic leukemia: A case report. Medwave, 23(04), e2664-e2664. https://doi.org/10.5867/medwave.2023.04.2664
Vancouver
Espinoza M, Ramírez P, Najima Y, Rojas-Vallejos J. Successful stem cell transplantation after nelarabine, pegylated asparaginase, vincristine, doxorubicin, and prednisone in refractory early T-cell precursor acute lymphoblastic leukemia: A case report. Medwave. 2023;23(04):e2664-e2664. doi:10.5867/medwave.2023.04.2664
BibTeX
@article{Espinoza2023,
author = {Espinoza, Marcela and Ramírez, Pablo and Najima, Yuho and Rojas-Vallejos, Jorge},
title = {Successful stem cell transplantation after nelarabine, pegylated asparaginase, vincristine, doxorubicin, and prednisone in refractory early T-cell precursor acute lymphoblastic leukemia: A case report},
journal = {Medwave},
year = {2023},
volume = {23},
number = {04},
pages = {e2664--e2664},
doi = {10.5867/medwave.2023.04.2664}
}
EUVIMED